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Introduction: There is a need to identify innovative,
low-cost and broad-reaching strategies for promoting
exercise and improving physical function in older
adults with multiple sclerosis (MS).
Methods and analysis: This randomised controlled
pilot trial will test the efficacy of a 6-month, DVD-
delivered exercise intervention to improve functional
performance and quality of life in older adults with MS.
Participants will be randomised either into a DVD-
delivered exercise condition or an attentional control
condition. This novel approach to programme delivery
provides participants with detailed exercise instructions
which are presented in a progressive manner and
includes a variety of modifications to better meet
varying levels of physical abilities. The targeted
exercises focus on three critical elements of functional
fitness: flexibility, strength and balance. It is
hypothesised that participants who are randomised to
the exercise DVD condition will demonstrate
improvements in physical function compared with
participants assigned to the attentional control
condition. Data analysis will include a 2 (condition)×2
(time) mixed factor analysis of variance (ANOVA) that
follows intent-to-treat principles, as well as an
examination of effect sizes. Participants will take part in
qualitative interviews about perspectives on physical
activity and programme participation.
Ethics and dissemination: The study protocol was
approved by a university institutional review board and
registered with a federal database. Participants will be
asked to read and sign a detailed informed consent
document and will be required to provide a physician’s
approval to participate in the study. The exercise DVDs
include an overview of safety-related concerns and
recommendations relative to exercise participation, as
well as detailed instructions highlighting the proper
execution of each exercise presented on screen.
Following completion of this trial, data will be
immediately analysed and results will be presented at
scientific meetings and published in scholarly journals.
Trial registration number: Clinical Trials
NCT01993095.
INTRODUCTION
The older adult population is in the midst
of unprecedented growth and is projected
to make-up 21% of the US population by
2040.1 This dramatic change in the demo-
graphic landscape presents significant
medical, societal and economic challenges,2
particularly as older age is generally accom-
panied by reductions in physical function
and increased levels of disability.3–5 These
seemingly inherent consequences of aging
can often be further exacerbated by the
onset and/or progression of chronic disab-
ling diseases, such as multiple sclerosis
(MS). The prevalence of MS, a progressive
neurodegenerative disease that affects the
central nervous system,6 is estimated to be
2.3 million people worldwide, with more
than 400 000 cases in the USA alone,7 and
45% are aged 55 years and older.8 Even with
variations in the pathological manifestations
of MS, some of the most common symptoms
and impairments mirror those that are char-
acteristically associated with aging, such as
reduced strength, difficulties with balance,
mobility, and coordination, frequent fatigue,
cognitive dysfunction, and compromised
Strengths and limitations of this study
▪ Innovative, broad-reaching design for delivery of
a physical activity programme to older adults
with multiple sclerosis (MS) via DVD.
▪ Progressive 6-month exercise programme with
built-in modifications to meet varying physical
abilities.
▪ Efficacy of using a DVD-delivered exercise inter-
vention to older adults with MS to improve phys-
ical function and quality of life remains to be
determined.
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quality of life (QOL).9–11 Unfortunately, there is a
dearth of research examining these outcomes in older
adults with MS.12 13
Physical inactivity among individuals with MS14 may
exacerbate problems associated with this chronic con-
dition. Physical activity participation, by comparison,
can confer a protective and potential restorative effect
on functional limitations and disability in older adults
with MS15–17 and may also have a protective effect on
the rate of disease progression.18 Thus, it is imperative
to establish methods to increase levels of physical activ-
ity engagement in the MS population. Although a
number of exercise interventions have been safely and
successfully implemented for more general or younger
segments of the MS population,19–21 to the best of our
knowledge, there have been no interventions designed
for and specifically targeting older adults with MS.
Additionally, the majority of MS-specific exercise inter-
ventions tend to be supervised, centre-based (eg,
fitness centres, university laboratories, medical settings,
etc) programmes, which can provide challenges to par-
ticipation, in terms of accessibility and ultimately
resulting in limited generalisability.22 Additionally,
centre-based programmes have limited reach, can be
difficult to implement, and are often resource inten-
sive (eg, costs, time, staff, etc). There is a need to
identify innovative, low-cost and broad-reaching strat-
egies specifically aimed at improving physical function
and, as a result, delaying (or at the very least minimis-
ing) the progression of functional limitations and dis-
ability in older adults with MS.
Targeted exercise training via DVD may be one con-
temporary approach in achieving this goal. Commercial
revenue for exercise DVDs exceeded $260 million in
the past 5 years and demand remains high, especially
among older adults.23 The efficacy of delivering such
programmes via DVD to improve physical function in
older adults living with chronic disease remains to be
determined. A recent study examined the efficacy of a
progressive, home-based, DVD-delivered exercise pro-
gramme (ie, FlexToBa) focusing on improving flexibility,
strength and balance in low-active community-dwelling
older adults (N=307).24 Participants randomised to the
exercise DVD condition showed significant improve-
ments on the Short Physical Performance Battery
(SPPB),25 as well as on measures of strength and upper
and lower extremity flexibility. Additionally, this novel
DVD-delivered intervention appears to be safe and well
tolerated, with participants reporting high levels of sat-
isfaction and a respectable rate of adherence, particu-
larly for a home-based exercise programme (∼75%
across the 6 months).24 It should be noted, however,
that while participants experienced gains in measures
of functional performance, the study sample still had
arguably high levels of function at baseline. Older
adults with MS would be expected to have more com-
promised levels of function than this healthier and
higher functioning sample.
METHODS
Study design and primary objectives
The design is a two-arm, 6-month randomised controlled
trial with participants randomised to either the FlexToBa
DVD (ie, exercise) condition or a Healthy Aging DVD (ie,
attentional control) condition (see figure 1). Stratified
randomisation by age and sex will be conducted to
ensure similar demographic characteristics between the
two conditions and to control for the potential influence
of these covariates on study outcomes. The objective of
this pilot trial is to test the efficacy of a DVD-delivered
exercise intervention designed to enhance physical func-
tion (eg, mobility, strength and flexibility) in older adults
with MS. Although this programme was initially devel-
oped for low-active, community-dwelling older adults,24
we believe that it may be appropriate for individuals with
MS, as well, particularly given their limited engagement
in physical activity and high degree of functional limita-
tions. Primary outcomes include physical function per-
formance and QOL. We hypothesise that older adults
with MS randomised to the exercise DVD condition
will demonstrate improvements in markers of physical
function (ie, flexibility, strength and balance), physical
activity and QOL compared with participants assigned to
the attentional control condition. Effect sizes generated
from this pilot trial will assist in powering a future defini-
tive trial. Additionally, qualitative interviews will be con-
ducted post-intervention to further assess participants’
attitudes towards physical activity and experience in the
intervention.
Participants
We will recruit 50 persons with MS who are aged 50 years
and older throughout the state of Illinois and from
western Indiana. This sample size was selected primarily
due to the narrow time frame of the funding period, as
well as to generate effect sizes for the primary outcomes.
Recruitment strategies and procedures
Recruitment materials will highlight the opportunity to
participate in a free, professionally developed, in-home
physical activity programme designed to enhance ele-
ments of physical fitness that have implications for the
successful maintenance of independent living in older
adults with MS. The recruitment plan is to distribute
study announcements through multiple avenues, such as
contacting previous research participants with MS via
phone, distributing flyers and brochures highlighting this
research opportunity, sending programme information
via MS-specific listsrvs, and posting web-based advertise-
ments (eg, the website of the Greater Illinois chapter of
the National Multiple Sclerosis Society). Study and
recruitment information will also be distributed at
various MS support meetings. Finally, we plan to utilise a
large local hospital as a recruitment source. All ads will
encourage interested participants to contact the research
coordinator by phone or email for more detailed study
information. A toll-free phone number will be available
2 Wójcicki TR, et al. BMJ Open 2014;4:e006250. doi:10.1136/bmjopen-2014-006250
Open Access
 on 14 S
eptem









pen: first published as 10.1136/bm






for people outside the local calling area and a pre-
screening telephone script will be used to determine eli-
gibility prior to scheduling testing appointments.
Eligibility criteria
Inclusion criteria for participation will be: a definite
diagnosis of MS that is confirmed in writing by the parti-
cipant’s neurologist or primary physician; being seden-
tary or physically inactive (ie, not regularly engaging in
physical activities of ≥30 min on more than 2 days of the
week during the past 6 months); aged 50 years or older;
fluent in English; ambulatory with minimal assistance
(ie, walk independently or with an assistive walking
device); the provision of medical clearance for participa-
tion in a physical activity programme by participants’
physicians; and an Expanded Disability Status Scale
(EDSS) score of less than 6.5 (ie, constant bilateral assist-
ance).26 The EDSS cut-off was selected for concerns
Figure 1 Study flow chart.
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with patient safety (ie, falls). Additionally, during the
pre-screening phone call, cognitive impairment will be
assessed by using the Modified Telephone Interview for
Cognitive Status (ie, TICS-M) questionnaire to assess
cognitive status.27 Potential subjects who score below 21
(of 39) on the TICS-M will be excluded from the trial.
Potential participants who meet eligibility criteria and
successfully pass the pre-screening will receive a letter
inviting them to participate, a document requesting
authorisation to contact their physician for clearance to
participate, an informed consent document (including
an additional copy for their personal records), and a
self-addressed stamped envelope to return these docu-
ments. The study’s research coordinator will be respon-
sible for managing these mailings. On receipt of the
signed documents, the research coordinator will file the
informed consent form and contact the physician for
the necessary clearance.
Scheduling
Following receipt of the signed informed consent docu-
ment and obtaining medical clearance, participants will
be scheduled (via phone) for a 2 h baseline testing visit
at a university research laboratory. They will also be
scheduled for a programme orientation meeting relative
to the expectations of the programme and participant
roles within their randomly assigned treatment condi-
tion. Finally, participants will be mailed an acceptance
letter, a testing and orientation appointment sheet, a
map with parking information and directions to the
testing locale, and a battery of questionnaires to be com-
pleted at home and returned at the scheduled baseline
testing session.
Primary study outcomes
Assessors who are blinded regarding treatment alloca-
tion will conduct assessments at baseline and again at
6 months, following programme termination. Details
regarding the measures used for primary outcomes (ie,
physical function performance and QOL), as well as a
list of secondary outcome measures (eg, physical activity,
cognition and psychosocial constructs), can be found in
table 1.
To strengthen our measurement approach, we will
include measures that are used in the gerontology litera-
ture and complement them with measures used in the
MS literature when possible. Tests of physical and cogni-
tive function will be administered onsite in a research
laboratory, psychosocial measures will be collected via a
battery of questionnaires, and physical activity levels will
be objectively assessed over a 7-day period. If needed,
participants will be allowed to use assistive devices while
performing walk-related assessments. A standardised
testing script, which provides detailed assessment
instructions, proposed demonstrations and safety-related
recommendations, will be utilised to ensure uniformity
of administration. Testing staff are experienced in the
common functional assessments used in MS and will
undergo extensive training prior to testing to ensure
accuracy and consistency in data collection.
Neurological disability
All participants will undergo an initial neurological
examination administered by a Neurostatus certified
examiner using the EDSS score.26 The EDSS is the ‘ref-
erent standard’ measure of disability in clinical trials in
MS. The EDSS is included for sample description only,
not as an outcome of the intervention.
Short Physical Performance Battery
The SPPB will be used to assess lower extremity function
via assessments of balance, mobility and leg strength.25
Participants will be instructed to complete a series of
balance tests sequentially (ie, gradually increasing in
terms of physical challenge). This is a three-part test in
which each balancing position must be successfully com-
pleted prior to moving on to the next, more challenging
task. Participants will first undergo the side-by-side stand
test (ie, standing with the medial sides of their feet
placed together), followed by the semitandem stand test
(ie, standing while touching the medial side of the heel
of one foot to the medial side of the big toe on the
other), and finally the tandem stand test (ie, standing
with the heel of one foot touching the tip of big toe on
the other foot). Balance must be maintained for 10 s
prior to proceeding to subsequent tests. Should a partici-
pant not successfully reach the 10 s mark(s), their
testing for the balance portion of the SPPB is con-
cluded. Testing staff will use stopwatches to evaluate and
record the length of time each position (if applicable) is
held.
The next component of the SPPB is the gait speed
test. Participants will be encouraged to complete this
task without an assistive walking device (eg, cane and
walker); however, they will be permitted to use assistance
should they feel unsafe or uncomfortable completing
the walking task after being presented with testing
instructions. Participants will be asked to approach a
clearly marked, 4 m course where they will be instructed
to walk briskly through the end of the course. This
assessment will be conducted twice and the time taken
to complete each walk will be recorded.
The final component of the SPPB is the two-part chair
stand test that is designed to assess lower extremity
strength. First, participants will be instructed to sit in a
chair and then, when ready, stand from the seated pos-
ition without the use of arms or an assistive device.
Should this first task be completed successfully, the par-
ticipant will be allowed to complete the subsequent
repeated chair stand test. If a participant is unable to
stand from the seated position, the test is complete and
they will not move forward to the second portion of the
test. Those who move on to the repeated chair stand test
will be provided with the same instructions in terms of
standing up from a seated position; however, for this par-
ticular part of the test, they will be challenged to
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complete five chair stand movements in a row within
60 s. Testing staff will monitor time with a stopwatch and
will record the number of successful repetitions (up to
five) performed. Scores from each of these assessments
will be summed together to create a composite score
indicative of lower extremity function.
Senior Fitness Test
Selected components of the Senior Fitness Test28 will be
used to assess other elements of physical function not
included in the SPPB. First, they will complete a 6 min
walk to assess walking endurance. A walking course will
be set-up for the participant, where they will be
instructed to walk as quickly yet safely for six continuous
minutes with the goal of covering as much ground as
possible. Time will be kept with a stopwatch and the
total distance walked will be measured via a distance
wheel. Testing staff will follow the participant from
behind, as to not influence the chosen walking speed,
while pushing a distance wheel along the walked course.
Second, a 30 s arm curl test will be conducted to
assess upper-body strength. During this task, participants
will be asked to sit near the side of a chair while holding
a dumbbell and completing as many arms curls as pos-
sible within 30 s. Females will be provided with a
5-pound weight for this task, while males will be asked to
use an 8-pound weight. Should participants be unable to
hold onto the dumbbell, weight-matched wrist weights
will be provided as an alternative. Again, staff will use a
stopwatch to monitor the time and will count, tally, and
record the number of repetitions performed.
Next, upper-body flexibility will be assessed using the
back-scratch test. Participants will first be instructed to
take one hand and place it over the same-side shoulder
with their palm facing down, fingers extended, and elbow
pointed up. Participants will then reach down the middle
of their back as far as they can. Once in place, they will be
asked to place their remaining hand behind their back
with the palm facing outward, with the goal of reaching
up as far as they can to touch or overlap their extended
middle fingers. As soon as the participant is in position,
Table 1 Primary study outcome measures*
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QOL Global QOL 1–5 Higher
value=improved QOL
Diener et al34
*Secondary measures include: accelerometry (Actigraph, Pensacola, Florida, USA; Models GT1M or GT3X); body mass index; Brief
International Cognitive Assessment for Multiple Sclerosis;35 Exercise Goal-Setting Scale and Exercise Planning and Scheduling Scale;36
Exercise Self-Efficacy Scale;37 Fatigue Severity Scale;38 Frequency of Forgetting Scale;39 Gait Efficacy Scale;40 Godin Leisure-Time Exercise
Questionnaire;41 Hospital Anxiety and Depression Scale;42 Abbreviated Late-Life Function and Disability Instrument;43 Lifestyle Self-Efficacy
Scale;44 Multidimensional Outcome Expectations for Exercise Scale;45 Multiple Sclerosis Walking Scale-12;46 Physical Self-Perception
Profile;47 Short-Form McGill Pain Questionnaire;48 Self-Efficacy for Walking Scale—Duration;49 Sitting-Time Questionnaire;50 UCLA
Loneliness Scale.51
Wójcicki TR, et al. BMJ Open 2014;4:e006250. doi:10.1136/bmjopen-2014-006250 5
Open Access
 on 14 S
eptem









pen: first published as 10.1136/bm






the tester will measure the distance between or over-
lapped by the two middle fingers with a ruler and record
the reading.
And finally, the chair sit-and-reach test will be used to
measure lower body flexibility. For this assessment partici-
pants will be instructed to sit near the front end of a
chair while bending one leg, with feet flat on the floor,
and extending the other, with only the heel touching the
floor and toes pointed up towards the ceiling. The hands
should then be set so that one is on top of the other with
the tips of the middle fingers perfectly aligned. When in
position, the participant will be told to reach as far
forward towards their toes on the extended leg as they
possibly can. The distance between the tip of their
middle fingers and the tip of their shoe on the extended
leg will be measured with a ruler and recorded.
Timed 25-foot walk
The timed 25-foot walk component of the Multiple
Sclerosis Functional Composite will be used to assess par-
ticipant mobility and gait-speed.29 Two trials will be con-
ducted along a marked course and assistive devices will
be allowed during this task, if needed. The time used to
complete these two trials will be monitored using a
stopwatch.
Grip strength
A hand-held dynamometer ( Jamar—Hydraulic Hand
Dynamometer, Sammons Preston Rolyan, Bolingbrook,
Illinois 60440, USA) will be used to measure grip
strength.30 Assessments will be conducted twice on each
hand in an alternating fashion. Participants will be asked
to keep the arm being tested at a 90° angle against the
side of their body. The tester will then place the
dynamometer in the participant’s hand and then ask
the participant to squeeze the device as hard as they can
for at least 3 s. The force generated will be displayed on
the dial of the dynamometer and will be immediately
recorded prior to moving on to the other hand.
One leg stand
Balance will be assessed using a one leg stand test.31
This assessment measures how long the participant can
hold their balance on each of their legs for up to 30 s.
Participants will be given one attempt on each leg and
the tester will monitor the passing time with a stopwatch.
Time will be recorded for the full 30 s unless the partici-
pants loses balance before time runs out (eg, hops,
drops their raised foot to the floor).
Quality of life
The unidimensional, 8-item Leeds Multiple Sclerosis
Quality of Life Scale will be used as a disease-specific
measure of overall QOL.32 An example item is: ‘I have
felt happy about the future.’ The scores range between
8 and 32, with lower scores representing better QOL.
This scale has good internal consistency, test–retest reli-
ability, evidence of score validity, and virtually no floor
or ceiling effects.32 As an additional MS-specific
measure, the 29-item Multiple Sclerosis Impact Scale will
be used to assess the physical (20 items) and psycho-
logical components (9 items) of health-related QOL in
persons with MS.33 An example item from the physical
scale is: “In the past two weeks, how much have you
been bothered by problems with balance?” An example
item from the psychological scale is: “In the past two
weeks, how much have you been bothered by feeling
depressed?” Scores range between 0 and 100, with lower
values representing greater health-related QOL. There is
evidence for the reliability and validity of the MSIS-29 in
samples of individuals with MS.52 Finally, the Satisfaction
with Life Scale will be used as a global measure of
QOL.34 This five-item, unidimensional scale asks partici-
pants to rate statements, such as ‘I am satisfied with my
life,’ on a seven-point Likert scale. The scores can range
between 7 and 35, with higher scores representing
higher QOL. This measure is commonly used in psycho-
social research and has good internal consistency, test–
retest reliability, and evidence of score validity.53
Qualitative inquiry
As part of the mixed methods research design all partici-
pants will be asked to participate in a semistructured
one-to-one qualitative interview. Interviews will be under-
taken on the final day of testing by the same assessor
who completed the quantitative assessments. A semi-
structured interview script will be followed to ensure
consistency. Interviewers will receive training from an
experienced qualitative researcher in MS. The interviews
will establish data on three primary areas: (1) the partici-
pant’s views on one’s daily activity practices (eg, “To help
me better understand, can you tell me what you think of
as physical activity?”); (2) the perceived consequences
from taking part in the study (eg, “Were there any pro-
blems or non-beneficial experiences you could tell me
about from following the program?”) and (3) partici-
pants’ views on general participation in the study and
future plans (eg, “Overall, thinking about the entire
program, what factor do you think was the most import-
ant?”). The data will be recorded, transcribed and ana-
lysed using a spiral approach54 whereby the researchers
will move through a series of analytical circles which
involve reading, memoing the data (ie, making notes in
the transcriptions), describing, classifying and categoris-
ing the data into codes and themes in order to interpret
and present the qualitative data. The qualitative data will
be important for: explaining physical activity behaviours
in older adults with MS, establishing the perceived con-
sequences of participation in our programme, and gath-
ering feedback to refine future physical activity
interventions for older people with MS.
Secondary outcomes
A battery of secondary outcomes including measures of
physical activity, cognition, functional limitations and
pain will be assessed pre-intervention and post-
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intervention. The complete list of secondary outcomes is
shown in table 1.
Testing appointments
All testing sessions, at both time points, will be con-
ducted and supervised by individuals who are cardiopul-
monary resuscitation (CPR) certified and have
undergone extensive training to minimise the risk to
participants. The research team responsible for adminis-
tering the tests will be blinded regarding participants’
treatment allocation. Next, participants will complete a
series of clinical, functional and cognitive tests. The
order of these assessments will be predetermined and
standardised. Furthermore, participants will be provided
with periods of rest throughout the testing session to
help minimise potential fatigue that may result from par-
ticipation in the functional fitness tests. Specifically, par-
ticipants will complete the 25-foot walk first, followed by
3 min of rest before completing the 6 min walk.
Subsequent functional assessments will be followed by
additional breaks and participants will be encouraged to
request additional periods of rest should they need it.
Finally, prior to departing from their baseline appoint-
ment, participants will receive an initialised accelerom-
eter to objectively measure physical activity levels along
with a corresponding wear-time log. Research staff will
provide verbal and written instructions, as well as a self-
addressed, stamped envelope for the return of the accel-
erometer and wear-time log via the USA Postal Service.
Participants will be instructed to wear the accelerometer
for full 7 days before mailing the device back to the
laboratory.
Interventions
The intervention was previously tested among older
adults without MS and has been described elsewhere.24
The intervention group will receive basic exercise equip-
ment (ie, resistance bands, yoga mat and exercise logs)
and a total of three DVDs: one orientation disc and two
discs containing six progressive exercise sessions. The
orientation DVD will include a brief overview of the exer-
cise programme, and a discussion of, and focus on, the
importance of strength, balance and flexibility exercises
for the maintenance of physical function. This disc will
also provide an introduction to the exercise leaders and
models, deliver detailed information regarding the
proper completion of the programme-specific exercise
logs, and address safety-related concerns. The six exercise
sessions presented within the other two DVDs are com-
prised of an orchestrated sequencing of progressions (ie,
beginning with simpler, more basic movements, and then
building on exercises learned to ultimately engage in
more complex movements). Delivering the exercise pro-
gramme in such a manner helps to ensure that new chal-
lenges are built on a previous foundation and to help
minimise the risk of injury. Participants will be instructed
to inform research staff of any adverse events that might
occur as a result of participation. This information will be
documented, reported to the Institutional Review Board,
and discussed in future publications regarding study out-
comes. Furthermore, each of the exercises presented
within the DVDs will include two additional versions that
vary in difficulty to make the exercises more attainable or
challenging for individuals of varying functional capabil-
ities and to further reduce the risk of injury.
Using the standing military press exercise as an
example, the exercise leader will instruct participants to
stand straight with their feet in a staggered position
while placing the centre of an exercise band directly
between the front foot and the floor. She will then
instruct them to grab the handles of the bands and pos-
ition their hands so that the palms face forward/
outward (ie, towards the direction of the TV for those
doing the exercise at home). Next, participants will be
told to form a ‘goal post’ type position with their arms
(ie, elbows in line with shoulders and forearms perpen-
dicular with the ground). From this starting position,
participants will be told to extend their elbows and
press/raise their hands straight up over their head in a
slow and controlled manner and up to the point
where their thumbs almost touch. They will then be
instructed to slowly lower the band back to starting
position to complete one repetition. To modify the mili-
tary press, participants will be encouraged to use light
hand weights as opposed to standing on an exercise
band, as this will provide less resistance and greater
range of motion. To make the exercise more challen-
ging, participants will be instructed to stand with both
feet evenly spaced on the band while performing the
movement, which will considerably increase the level of
resistance.
Participants in the FlexToBa group will be instructed to
exercise with the DVDs on a regular basis (ie, every
other day or at least three times per week) and to com-
plete and mail in the exercise logs on a monthly basis
via previously provided self-addressed stamped envel-
opes. These logs will be collected and entered by select,
unblinded research personnel, who will also be respon-
sible for generating and mailing personalised pro-
gramme feedback to the corresponding participants for
each of the six monthly exercise sessions. These detailed
feedback forms will provide graphic progress reports for
the most recently completed exercise session (ie, days
exercised with the DVD, days of other exercises outside
of the programme, average time spent exercising, and
averages of programme-specific ratings of perceived
exertion and enjoyment). The form will include some
written feedback relative to performance and progress
and will also provide constructive and motivational com-
ments and suggestions. Moreover, participants in this
condition will receive brief (ie, <5 min) support calls
from select unblinded staff members in a titrated
fashion (ie, twice a month during the first 2 months of
the programme, and then once a month for the remain-
der of the programme). The purpose of these calls is to
simply check in on participant progress and/or setbacks
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(ie, injury), answer any programme-specific questions or
concerns, confirm receipt and provide an overview of
their personalised monthly feedback, and to provide
some advice regarding exercise participation (ie, an
‘exercise tip’).
Participants in the attentional control condition will
receive a copy of Dr Andrew Weil’s Healthy Aging DVD,
which focuses on various elements of successful aging but
is not in and of itself specific to exercise. Participants will
be asked to watch this DVD at least once in its entirety.
This group will also receive brief, titrated support calls
from the research staff. These calls will fall in line with
the support call schedule for the exercise condition and
will include an overview of one of the Healthy Aging DVD
topics (eg, the importance of proper nutrition, social
support, etc) along with some advice related to that par-
ticular topic (ie, ‘healthy aging tip’).
Post-intervention testing at month 6
All assessments will be completed again at month 6, fol-
lowing the full completion of the 6-month exercise pro-
gramme. When participants are scheduled for follow-up
testing sessions, they will be reminded of the testing
location, invited to participate in the qualitative inter-
views, and reminded not to disclose their group alloca-
tion to the assessing research team. All testing will take
place at the same location as baseline testing, and will
be administered by blinded research staff. Testing proce-
dures will mirror those presented at baseline. Following
completion of the follow-up appointment, control parti-
cipants will be given the exercise DVDs and accessories
prior to leaving. Additionally, all participants who com-
plete the programme and related assessments, regardless
of treatment allocation, will receive a total of $175 for
their time and travel-related expenses.
Data management
The principal investigators will be responsible for oversee-
ing data collection, entry and management. Questionnaire
data will be checked immediately in the presence of the
research participant if possible for clarity and complete-
ness at the time of collection. For data provided by mail,
follow-up telephone calls to clarify missing data will be
made. If necessary, incomplete or ambiguous results will
be corrected with follow-up telephone calls and/or add-
itional appointments with research staff. Data obtained
from the onsite testing sessions will be entered onto a
scorecard as the tests are performed and scores made
available. Physical activity data provided by the accelerom-
eter will be downloaded and scored using MS-specific cut
points55 to determine the amount of physical activity
engagement at varying intensities. The corresponding
accelerometer logs will be used to validate wear time.
Data analysis
The proposed data analysis will be a 2 (FlexToBa vs
Healthy Aging condition)×2 (time) mixed factor analysis
of variance (ANOVA) that follows intent-to-treat
principles. Missing data will be handled via multiple
imputation analysis. F-statistics will be decomposed
using post hoc analyses including paired and independ-
ent samples t tests with a Dunn-Bonferroni correction of
α. Effect sizes for F-statistics and differences in mean
scores will be expressed as partial η2 and Cohen’s d,
respectively.
ETHICS AND DISSEMINATION
Additionally, the trial was registered with ClinicalTrials.
gov (NCT01993095). Prior to study involvement, all par-
ticipants who meet eligibility criteria will be presented
with and asked to sign an informed consent document
detailing the study’s purpose, assessments and data col-
lection, risks and benefits, privacy and rights, costs and
remuneration, and contact information. The informed
consent document also stresses the fact that participa-
tion in this project is entirely voluntary and that partici-
pants are free to withdraw from the study at any time
without penalty. Furthermore, confidentiality is assured
for all participants with regard to any personal responses
and information provided throughout the trial. All data
collected will be numerically coded and aggregated;
therefore, no individual data will be identifiable. Results
from this study will be presented at scientific meetings
and published in scholarly journals.
DISCUSSION
The purpose of this randomised controlled pilot trial
is to test the efficacy of a 6-month, home-based, DVD-
delivered exercise programme physical function and
QOL in older adults with MS. Given that this pro-
gramme was found to be efficacious in a large sample of
relatively healthy community-dwelling older adults,24 we
hypothesise that older adults with MS who get assigned
to the exercise condition will experience similar if not
greater effects on the physical function. Persons with MS
are typically less active than their healthy counterparts
and generally suffer from a higher degree functional
limitations and disabilities than other older adults
without chronic conditions. If participants in the exer-
cise condition of this trial experience maintenance or
improvements in physical function as a result of pro-
gramme engagement, it could lead to improvements in
QOL and may ultimately have a considerable impact on
public health, especially for those within the MS com-
munity. While the low levels of physical function among
this sample may present some unique challenges in
terms of adherence to and progress with the exercise
programme, we believe that the progressive nature of
the programme, along with built-in exercise modifica-
tions and routine support calls, should adequately assist
in minimising attrition and enhancing engagement.
However, future studies will be needed to determine the
effectiveness of delivering such an exercise programme
without the regular contact and support of a research
team. Nevertheless, this innovative mode of programme
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delivery possesses the potential for broad-scale dissemin-
ation and should be well-received by those affected by
chronic disabling diseases due to its progressive and
modifiable nature.
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